Previous studies have demonstrated that the percentage of CD4+ T cells and the ratio of CD4+/CD8+ decreased in patients with PNS, which in turn led to reduced immune function; therefore, the PNS PBMC showed now clear inhibitory effects on tumor cells in vitro (21,22). This evidence concerns the gene CD4 and paraneoplastic neurologic syndrome.